China Immunotherapy Drugs Market (2025-2031) | Outlook, Supply, Competitive, Consumer Insights, Restraints, Strategic Insights, Forecast, Segments, Share, Industry, Size, Pricing Analysis, Demand, Companies, Analysis, Strategy, Investment Trends, Growth, Value, Revenue, Trends, Drivers, Segmentation, Opportunities, Competition, Challenges

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Immunotherapy Drugs Market Revenues & Volume, 2021 & 2031F

3.3 China Immunotherapy Drugs Market - Industry Life Cycle

3.4 China Immunotherapy Drugs Market - Porter's Five Forces

3.5 China Immunotherapy Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.6 China Immunotherapy Drugs Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F

3.7 China Immunotherapy Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F

3.8 China Immunotherapy Drugs Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F

3.9 China Immunotherapy Drugs Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in China

4.2.2 Growing awareness about the benefits of immunotherapy

4.2.3 Government initiatives to promote healthcare access and innovation in immunotherapy

4.3 Market Restraints

4.3.1 High cost of immunotherapy drugs

4.3.2 Limited availability and accessibility of advanced immunotherapy treatments in rural areas of China

6.1 China Immunotherapy Drugs Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 China Immunotherapy Drugs Market Revenues & Volume, By Drug Type, 2021 - 2031F

6.1.3 China Immunotherapy Drugs Market Revenues & Volume, By Checkpoint Inhibitors, 2021 - 2031F

6.1.4 China Immunotherapy Drugs Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F

6.1.5 China Immunotherapy Drugs Market Revenues & Volume, By Cancer Vaccines, 2021 - 2031F

6.1.6 China Immunotherapy Drugs Market Revenues & Volume, By Cytokines, 2021 - 2031F

6.1.7 China Immunotherapy Drugs Market Revenues & Volume, By Adoptive T-Cell Therapy, 2021 - 2031F

6.2 China Immunotherapy Drugs Market, By Cancer Type

6.2.1 Overview and Analysis

6.2.2 China Immunotherapy Drugs Market Revenues & Volume, By Lung Cancer, 2021 - 2031F

6.2.3 China Immunotherapy Drugs Market Revenues & Volume, By Breast Cancer, 2021 - 2031F

6.2.4 China Immunotherapy Drugs Market Revenues & Volume, By Melanoma, 2021 - 2031F

6.2.5 China Immunotherapy Drugs Market Revenues & Volume, By Leukemia, 2021 - 2031F

6.2.6 China Immunotherapy Drugs Market Revenues & Volume, By Multiple Myeloma, 2021 - 2031F

6.3 China Immunotherapy Drugs Market, By End User

6.3.1 Overview and Analysis

6.3.2 China Immunotherapy Drugs Market Revenues & Volume, By Oncology Centers, 2021 - 2031F

6.3.3 China Immunotherapy Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F

6.3.4 China Immunotherapy Drugs Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F

6.3.5 China Immunotherapy Drugs Market Revenues & Volume, By Research Institutions, 2021 - 2031F

6.3.6 China Immunotherapy Drugs Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F

6.4 China Immunotherapy Drugs Market, By Mechanism of Action

6.4.1 Overview and Analysis

6.4.2 China Immunotherapy Drugs Market Revenues & Volume, By PD-1/PD-L1 Blocking, 2021 - 2031F

6.4.3 China Immunotherapy Drugs Market Revenues & Volume, By Immune System Activation, 2021 - 2031F

6.4.4 China Immunotherapy Drugs Market Revenues & Volume, By Tumor Cell Recognition, 2021 - 2031F

6.4.5 China Immunotherapy Drugs Market Revenues & Volume, By Signal Pathway Modulation, 2021 - 2031F

6.4.6 China Immunotherapy Drugs Market Revenues & Volume, By CAR-T Cell Therapy, 2021 - 2031F

6.5 China Immunotherapy Drugs Market, By Sales Channel

6.5.1 Overview and Analysis

6.5.2 China Immunotherapy Drugs Market Revenues & Volume, By Direct Sales, 2021 - 2031F

6.5.3 China Immunotherapy Drugs Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F

6.5.4 China Immunotherapy Drugs Market Revenues & Volume, By Wholesale Suppliers, 2021 - 2031F

6.5.5 China Immunotherapy Drugs Market Revenues & Volume, By Government Procurement, 2021 - 2031F

6.5.6 China Immunotherapy Drugs Market Revenues & Volume, By Hospital Contracts, 2021 - 2031F

7.1 China Immunotherapy Drugs Market Export to Major Countries

7.2 China Immunotherapy Drugs Market Imports from Major Countries

8.1 Number of clinical trials for immunotherapy drugs conducted in China

8.2 Adoption rate of immunotherapy treatments in major cities

8.3 Investment in research and development of new immunotherapy drugs in China

9.1 China Immunotherapy Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.2 China Immunotherapy Drugs Market Opportunity Assessment, By Cancer Type, 2021 & 2031F

9.3 China Immunotherapy Drugs Market Opportunity Assessment, By End User, 2021 & 2031F

9.4 China Immunotherapy Drugs Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F

9.5 China Immunotherapy Drugs Market Opportunity Assessment, By Sales Channel, 2021 & 2031F

10.1 China Immunotherapy Drugs Market Revenue Share, By Companies, 2024

10.2 China Immunotherapy Drugs Market Competitive Benchmarking, By Operating and Technical Parameters